MedinCell Financials
| MDCLF Stock | USD 6.98 0.00 0.00% |
MedinCell |
MedinCell Stock Summary
MedinCell competes with BioInvent International, Avacta Group, Healios KK, PureTech Health, and GenSight Biologics. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception mdc-ANG for CNS related treatments mdc-ELK for depression and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. Medincell is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 3 rue des |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.medincell.com |
| Phone | 33 4 67 02 13 67 |
| Currency | USD - US Dollar |
MedinCell Key Financial Ratios
There are many critical financial ratios that MedinCell's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that MedinCell SA reports annually and quarterly.MedinCell Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MedinCell's current stock value. Our valuation model uses many indicators to compare MedinCell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MedinCell competition to find correlations between indicators driving MedinCell's intrinsic value. More Info.MedinCell SA is rated below average in return on asset category among its peers. It is considered to be number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MedinCell's earnings, one of the primary drivers of an investment's value.MedinCell SA Systematic Risk
MedinCell's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MedinCell volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on MedinCell SA correlated with the market. If Beta is less than 0 MedinCell generally moves in the opposite direction as compared to the market. If MedinCell Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MedinCell SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MedinCell is generally in the same direction as the market. If Beta > 1 MedinCell moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for MedinCell Pink Sheet analysis
When running MedinCell's price analysis, check to measure MedinCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedinCell is operating at the current time. Most of MedinCell's value examination focuses on studying past and present price action to predict the probability of MedinCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedinCell's price. Additionally, you may evaluate how the addition of MedinCell to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |